INTERNATIONAL PATENT: RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE, 上海交通大学医学院附属瑞金医院 FILES APPLICATION FOR "USE OF GPR132 INHIBITOR FOR BLOCKING CCL20-CCR6 AXIS IN TREATMENT AND PREVENTION OF RECURRENCE OF PSORIASIS"

GENEVA, Jan. 7 -- RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (No. 197, Ruijin Road (No. 2)Huangpu District, Shanghai 200025), 上海交通大学医学院附属瑞金医院 (中国上海市黄浦区瑞金二路197号) filed a patent application (PCT/CN2025/117249) for "USE OF GPR132 INHIBITOR FOR BLOCKING CCL20-CCR6 AXIS IN TREATMENT AND PREVENTION OF RECURRENCE OF PSORIASIS" on Aug 27, 2025. With publication no. WO/2026/002307, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent C...